Table 1 Characteristics and clinical features of patients with kidney involvement after COVID-19 infection
From: Kidney involvement in children during the SARS-CoV-2 Omicron variant pandemic
Pt | Age | Sex | Kidney | COVID-19 | Intervals | Underlying | Medication | Bx | Management | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|---|
No | (y) | involvement | Severity | Vaccination | (d) | disease | at presentation | ||||
1a | 9.5 | F | New-onset NS | Mild | - | 42 | - | - | - | Steroid | remission in 7d |
2 | 11.2 | M | NS relapse, GHU | Mild | - | 3 | SDNS (3.0y-) | FK506/ACEi | - | Steroid | remission in 10d |
3 | 6.8 | M | NS relapse | Mild | - | 23 | SDNS (3.2y-) | - | - | Steroid | remission in 14d |
4 | 9.7 | F | NS relapse | Mild | - | 21 | SSNS (4.9y-) | - | - | Steroid | remission in 6d |
5 | 4.8 | F | NS relapse | Mild | - | 7 | SSNS (3.9y-) | - | - | Steroid | remission in 9d |
6 | 8.8 | M | NS relapse | Mild | - | 1 | SRNS (3.5y-,) | FK506/steroid | MCD | Steroid | remission in 9d |
7 | 12.0 | F | NS relapse | Mild | - | 1 | SRNS (3.4y-) | - | MCD | Steroid | remission in 8d |
8 | 7.5 | M | GHU/PU (PrCR0.5) | Mild | - | 0 | KD (3y) | - | - | Observe | PU: Resolved in 9d |
HSP (6y) | mHU: persist | ||||||||||
9 | 15.0 | M | GHU/PU (PrCR1.4) | Moderate | - | 2 | CD (9.8y-) | Adalimumab | - | Hydration | RML/PU: Improved |
RML | mHU: persistent | ||||||||||
10 | 12.9 | F | GHU/PU (PrCR0.3) | Mild | - | 0 | - | - | - | Observe | mHU/PU: persist |
11 | 12.8 | F | GHU/AKI (eGFR 66 ml/min/m2) | Mild | 1 | 6 | IgAN (9.5y-) | ARB | IgAN | Observe | improved in 41d |
12 | 14.1 | M | GHU | Mild | 2 | 0 | IgAN (14.0y-) | AZA/ACEi | IgAN | Observe | mHU: persistent |
13a | 9.1 | F | GHU/NS (PrCR14.5) | Mild | - | 49 | DBA (birth-) | - | HSPNa | Steroid, | PU: Resolved in 47d |
after HSP | AZA | mHU: persistent | |||||||||
14 | 10.6 | M | AKI (eGFR 73 ml/min/m2) | Moderate | - | 0 | KT (5.8y, ARPKD) | FK506/MMF | - | Hydration | resolution in 2d |
15 | 18.3 | M | AKI (eGFR 49 ml/min/m2) | Moderate | 3 | 18 | KT (17.9y, IgAN) | FK506/MMF/steroid | - | Hydration | resolution in 112d |